Board of Directors

The Board of Stemina Biomarker Discovery is comprised of industry leaders with the business acumen and good judgment to lead us forward.

Elizabeth L. R. Donley, JD, MBA, MS

Chief Executive Officer

Barbara Handelin, PhD

C0-Founder, CEO - Audacity Therapeutics, PBC

R. Andrew Morgan, R.Ph

Executive Vice President Regulatory Affairs & Quality Operations - Zurex Pharma and Zurex PharmAgra

Marc Schneebaum

Senior Vice President and Chief Financial Officer – Madrigal Pharmaceuticals